CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designations for its clinical product candidate, cavrotolimod (AST-008), for two development programs: cavrotolimod in… Read More..

Shoop’s Leadership Experience Bridges Military, Academia, Industry and Not-for-Profit Sectors During Distinguished 40-Year Career London, UK, Jan. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Bubblr Inc., (OTC PINK: BBLR), ("Bubblr" or the "Company"), an ethical technology company focused on the development and commercialization of mobile-first technologies, today announced the… Read More..

-- Providing an end-to-end business solution for our customers -- Ensuring seamless integration of drug and light combination for both physicians and patients PRINCETON, N.J., Jan. 7, 2021 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat… Read More..